TY - JOUR
T1 - Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
AU - Patel, Kishan P.
AU - Patel, Puja A.
AU - Vunnam, Rama R.
AU - Hewlett, Alexander T.
AU - Jain, Rohit
AU - Jing, Ran
AU - Vunnam, Srinivas R.
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/7
Y1 - 2020/7
N2 - There is an increasing number of confirmed cases and deaths caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributing to the Coronavirus disease 2019 (COVID-19) pandemic. At this point, the need for further disease characterization is critical. COVID-19 is well established as a respiratory tract pathogen; however, recent studies have shown an increasing number of patients reporting gastrointestinal manifestations such as diarrhea, nausea, vomiting, and abdominal pain. The time from onset of gastrointestinal symptoms to hospital presentation is often delayed compared to that of respiratory symptoms. It has been noted that SARS-CoV-2 RNA can be detected in fecal matter for an extended period of time, even after respiratory samples have tested negative and patients are asymptomatic. In this article, SARS-CoV-2 and its disease COVID-19 will be reviewed with consideration of the latest literature about gastrointestinal symptomatology, the mechanisms by which the virus may inflict damage, and the possibility of viral replication contributing to a fecal-oral route of transmission.
AB - There is an increasing number of confirmed cases and deaths caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributing to the Coronavirus disease 2019 (COVID-19) pandemic. At this point, the need for further disease characterization is critical. COVID-19 is well established as a respiratory tract pathogen; however, recent studies have shown an increasing number of patients reporting gastrointestinal manifestations such as diarrhea, nausea, vomiting, and abdominal pain. The time from onset of gastrointestinal symptoms to hospital presentation is often delayed compared to that of respiratory symptoms. It has been noted that SARS-CoV-2 RNA can be detected in fecal matter for an extended period of time, even after respiratory samples have tested negative and patients are asymptomatic. In this article, SARS-CoV-2 and its disease COVID-19 will be reviewed with consideration of the latest literature about gastrointestinal symptomatology, the mechanisms by which the virus may inflict damage, and the possibility of viral replication contributing to a fecal-oral route of transmission.
UR - http://www.scopus.com/inward/record.url?scp=85085084847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085084847&partnerID=8YFLogxK
U2 - 10.1016/j.jcv.2020.104386
DO - 10.1016/j.jcv.2020.104386
M3 - Article
C2 - 32388469
AN - SCOPUS:85085084847
SN - 1386-6532
VL - 128
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
M1 - 104386
ER -